Cargando…
Defensive Driving: Directing HIV-1 Vaccine-Induced Humoral Immunity to the Mucosa with Chemokine Adjuvants
A myriad of pathogens gain access to the host via the mucosal route; thus, vaccinations that protect against mucosal pathogens are critical. Pathogens such as HIV, HSV, and influenza enter the host at mucosal sites such as the intestinal, urogenital, and respiratory tracts. All currently licensed va...
Autores principales: | Gary, Ebony N., Kutzler, Michele A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311813/ https://www.ncbi.nlm.nih.gov/pubmed/30648120 http://dx.doi.org/10.1155/2018/3734207 |
Ejemplares similares
-
A Little Help From the Follicles: Understanding the Germinal Center Response to Human Immunodeficiency Virus 1 Infection and Prophylactic Vaccines
por: Gary, Ebony N, et al.
Publicado: (2017) -
Adaptive HIV-Specific B Cell-Derived Humoral Immune Defenses of the Intestinal Mucosa in Children Exposed to HIV via Breast-Feeding
por: Moussa, Sandrine, et al.
Publicado: (2013) -
A Novel HIV Vaccine Adjuvanted by IC31 Induces Robust and Persistent Humoral and Cellular Immunity
por: Pattacini, Laura, et al.
Publicado: (2012) -
Chemokines as Cancer Vaccine Adjuvants
por: Bobanga, Iuliana D., et al.
Publicado: (2013) -
The Mucosae-Associated Epithelial Chemokine (MEC/CCL28) Modulates Immunity in HIV Infection
por: Castelletti, Eleonora, et al.
Publicado: (2007)